Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab-Reference-Cited by-同舟云学术

Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab

Published:2016-02-12 Issue:11 Volume:7 Page:13013-13030
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Haen Sebastian P.¹²,Schmiedel Benjamin J.¹,Rothfelder Kathrin¹³,Schmied Bastian J.¹³,Dang Truong-Minh²,Mirza Nora¹²,Möhle Robert¹,Kanz Lothar¹,Vogel Wichard¹,Salih Helmut R.¹³

Affiliation:

1. University Hospital Tuebingen, Department for Oncology, Hematology, Immunology, Rheumatology and Pulmonology, Tuebingen, Germany

2. Interfacultary Center for Cell Biology, Department for Immunology, Tuebingen, Germany

3. Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tuebingen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-02-01

2. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26

3. Antibody-Dependent Cell-Mediated Cytotoxicity Through Natural Killer (NK) Cells: Unlocking NK Cells for Future Immunotherapy;Current Pharmaceutical Biotechnology;2022-03

4. Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells;Bioconjugate Chemistry;2021-06-11

5. Clinically-driven design of synthetic gene regulatory programs in human cells;2021-02-23